Connie Tat | Senior Medical Science Director
Genentech

Connie has over 8 years of diverse experiences in the biotech/pharma industry in the US and globally in Medical Affairs, Clinical Development, and Commercial.  She is currently a Senior Medical Science Director in Oncology in Medical Affairs at Genentech, where she partners closely with the Product Development team on clinical trials.  Recently, she has been involved in a platform study of a clinical collaboration with BioNTech for a personalized mRNA cancer vaccine.  She is also involved in studies using ctDNA in oncology.  Prior to Genentech, she was at Amgen, where she launched LUMAKRAS (sotorasib; a first in class KRAS G12C inhibitor) in metastatic non-small cell lung cancer in Canada, Brazil, and UAE.  There, she also served as the Intercontinental Regional Medical Lead and developed the medical strategy for the oncology pipeline across solid tumors and hematology with assets of various modalities (from small molecules to bispecifics) in different stages of development.  She holds a Ph.D. in Immunology from the University of California, Irvine and her Bachelor’s in Molecular and Cellular Biology from the University of California, Berkeley.  She is passionate about translating innovative research and technology to improve patient outcomes and advancing future collaborations and strategies.